These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 20372020)
1. Evaluation of inhibitory effects of thiobarbituric acid derivatives targeting HCV NS5B polymerase. Lee JH; Lee S; Park MY; Ha HJ; Myung H J Microbiol Biotechnol; 2010 Mar; 20(3):510-2. PubMed ID: 20372020 [TBL] [Abstract][Full Text] [Related]
2. Characterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase. Lee JH; Lee S; Park MY; Myung H Virol J; 2011 Jan; 8():18. PubMed ID: 21235805 [TBL] [Abstract][Full Text] [Related]
3. Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase. Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Lai VC; Zhong W; Wu JZ Bioorg Med Chem Lett; 2005 Feb; 15(3):675-8. PubMed ID: 15664835 [TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives. Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995 [TBL] [Abstract][Full Text] [Related]
5. Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells. Beaulieu PL; Bousquet Y; Gauthier J; Gillard J; Marquis M; McKercher G; Pellerin C; Valois S; Kukolj G J Med Chem; 2004 Dec; 47(27):6884-92. PubMed ID: 15615537 [TBL] [Abstract][Full Text] [Related]
6. Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor. Chen Y; Bopda-Waffo A; Basu A; Krishnan R; Silberstein E; Taylor DR; Talele TT; Arora P; Kaushik-Basu N Antivir Chem Chemother; 2009 Sep; 20(1):19-36. PubMed ID: 19794229 [TBL] [Abstract][Full Text] [Related]
7. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase. Manfroni G; Meschini F; Barreca ML; Leyssen P; Samuele A; Iraci N; Sabatini S; Massari S; Maga G; Neyts J; Cecchetti V Bioorg Med Chem; 2012 Jan; 20(2):866-76. PubMed ID: 22197397 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives. Krueger AC; Madigan DL; Green BE; Hutchinson DK; Jiang WW; Kati WM; Liu Y; Maring CJ; Masse SV; McDaniel KF; Middleton TR; Mo H; Molla A; Montgomery DA; Ng TI; Kempf DJ Bioorg Med Chem Lett; 2007 Apr; 17(8):2289-92. PubMed ID: 17300933 [TBL] [Abstract][Full Text] [Related]
9. 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase. McGowan D; Nyanguile O; Cummings MD; Vendeville S; Vandyck K; Van den Broeck W; Boutton CW; De Bondt H; Quirynen L; Amssoms K; Bonfanti JF; Last S; Rombauts K; Tahri A; Hu L; Delouvroy F; Vermeiren K; Vandercruyssen G; Van der Helm L; Cleiren E; Mostmans W; Lory P; Pille G; Van Emelen K; Fanning G; Pauwels F; Lin TI; Simmen K; Raboisson P Bioorg Med Chem Lett; 2009 May; 19(9):2492-6. PubMed ID: 19342234 [TBL] [Abstract][Full Text] [Related]
15. Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase. Howe AY; Bloom J; Baldick CJ; Benetatos CA; Cheng H; Christensen JS; Chunduru SK; Coburn GA; Feld B; Gopalsamy A; Gorczyca WP; Herrmann S; Johann S; Jiang X; Kimberland ML; Krisnamurthy G; Olson M; Orlowski M; Swanberg S; Thompson I; Thorn M; Del Vecchio A; Young DC; van Zeijl M; Ellingboe JW; Upeslacis J; Collett M; Mansour TS; O'Connell JF Antimicrob Agents Chemother; 2004 Dec; 48(12):4813-21. PubMed ID: 15561861 [TBL] [Abstract][Full Text] [Related]
16. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition. Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371 [TBL] [Abstract][Full Text] [Related]
18. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase. Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470 [TBL] [Abstract][Full Text] [Related]
19. N-Acetamideindolecarboxylic acid allosteric 'finger-loop' inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies. Beaulieu PL; Jolicoeur E; Gillard J; Brochu C; Coulombe R; Dansereau N; Duan J; Garneau M; Jakalian A; Kühn P; Lagacé L; LaPlante S; McKercher G; Perrault S; Poirier M; Poupart MA; Stammers T; Thauvette L; Thavonekham B; Kukolj G Bioorg Med Chem Lett; 2010 Feb; 20(3):857-61. PubMed ID: 20074949 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication. Stankiewicz-Drogoń A; Dörner B; Erker T; Boguszewska-Chachulska AM J Med Chem; 2010 Apr; 53(8):3117-26. PubMed ID: 20337460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]